Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 119

    1.

    Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.

    Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR; Steering Committees of IDEAL and TNT Trials.

    Am J Cardiol. 2009 Aug 15;104(4):459-63. Epub 2009 Jun 24.PMID: 19660594 [PubMed - indexed for MEDLINE]Related articles

    2.

    Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).

    Johnson C, Waters DD, DeMicco DA, Breazna A, Bittner V, Greten H, Grundy SM, LaRosa JC.

    Am J Cardiol. 2008 Nov 15;102(10):1312-7. Epub 2008 Sep 5.PMID: 18993147 [PubMed - indexed for MEDLINE]Related articles

    3.

    The science of quality improvement.

    LaRosa JC.

    JAMA. 2008 Jul 23;300(4):391; author reply 391-2. No abstract available. PMID: 18647979 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

    Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM; TNT Study Group; IDEAL Study Group.

    Circulation. 2008 Jun 10;117(23):3002-9. Epub 2008 Jun 2.PMID: 18519851 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.

    Shah SJ, Waters DD, Barter P, Kastelein JJ, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC.

    J Am Coll Cardiol. 2008 May 20;51(20):1938-43.PMID: 18482661 [PubMed - indexed for MEDLINE]Related articles

    6.

    The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.

    Kostis JB, Breazna A, Deedwania PC, LaRosa JC; Treating to New Targets Steering Committee and Investigators.

    J Clin Hypertens (Greenwich). 2008 May;10(5):367-76.PMID: 18453796 [PubMed - indexed for MEDLINE]Related articles

    7.

    HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

    Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC; Treating to New Targets Investigators.

    N Engl J Med. 2007 Sep 27;357(13):1301-10.PMID: 17898099 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).

    LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H; Treating to New Targets (TNT) Steering Committee and Investigators.

    Am J Cardiol. 2007 Sep 1;100(5):747-52. Epub 2007 Jun 14.PMID: 17719314 [PubMed - indexed for MEDLINE]Related articles

    9.

    Means and ends of statins and low-density lipoprotein cholesterol lowering.

    LaRosa JC.

    J Am Coll Cardiol. 2007 Jul 31;50(5):419-20. Epub 2007 Jul 16. No abstract available. PMID: 17662393 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low-density lipoprotein cholesterol reduction: the end is more important than the means.

    LaRosa JC.

    Am J Cardiol. 2007 Jul 15;100(2):240-2. Epub 2007 May 24. Review.PMID: 17631077 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.

    Waters DD, LaRosa JC, Barter P, Fruchart JC, Gotto AM Jr, Carter R, Breazna A, Kastelein JJ, Grundy SM.

    J Am Coll Cardiol. 2006 Nov 7;48(9):1793-9. Epub 2006 Oct 17.PMID: 17084252 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

    Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD; Treating to New Targets Investigators.

    Lancet. 2006 Sep 9;368(9539):919-28.PMID: 16962881 [PubMed - indexed for MEDLINE]Related articles

    13.

    Coronary heart disease prevention in women: focus on lipids.

    Larosa JH, Larosa JC.

    Minerva Cardioangiol. 2006 Jun;54(3):311-22. Review.PMID: 16733505 [PubMed - indexed for MEDLINE]Related articles

    14.

    The benefits of statin therapy--what questions remain?

    Gotto AM Jr, LaRosa JC.

    Clin Cardiol. 2005 Nov;28(11):499-503. Review.PMID: 16450792 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cardiovascular risk factors in minorities.

    LaRosa JC, Brown CD.

    Am J Med. 2005 Dec;118(12):1314-22. Review.PMID: 16378771 [PubMed - indexed for MEDLINE]Related articles

    16.

    At the heart of the statin benefit.

    LaRosa JC.

    J Am Coll Cardiol. 2005 Nov 15;46(10):1863. Epub 2005 Oct 17. No abstract available. PMID: 16286172 [PubMed - indexed for MEDLINE]Related articles

    17.

    Is aggressive lipid-lowering effective and safe in the older adult?

    LaRosa JC.

    Clin Cardiol. 2005 Sep;28(9):404-7. Review.PMID: 16250262 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

    LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators.

    N Engl J Med. 2005 Apr 7;352(14):1425-35. Epub 2005 Mar 8.PMID: 15755765 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Primary prevention: the unsettling question.

    LaRosa JC.

    Curr Atheroscler Rep. 2005 Feb;7(1):1-2. No abstract available. PMID: 15683591 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cholesterol and coronary disease--the altered landscape.

    LaRosa JC.

    Cardiovasc Drugs Ther. 2004 Jan;18(1):9-10. No abstract available. PMID: 15228053 [PubMed - indexed for MEDLINE]Related articles

    21.

    Past, present, and future standards for management of dyslipidemia.

    LaRosa JC, Gotto AM Jr.

    Am J Med. 2004 Mar 22;116 Suppl 6A:3S-8S. Review.PMID: 15050186 [PubMed - indexed for MEDLINE]Related articles

    22.

    Reduction of serum LDL-C levels: a relationship to clinical benefits.

    LaRosa JC.

    Am J Cardiovasc Drugs. 2003;3(4):271-81. Review.PMID: 14728080 [PubMed - indexed for MEDLINE]Related articles

    23.

    New and emerging data from clinical trials of statins.

    LaRosa JC.

    Curr Atheroscler Rep. 2004 Jan;6(1):12-9. Review.PMID: 14662103 [PubMed - indexed for MEDLINE]Related articles

    24.

    Evidence-based management of dyslipidemias in women.

    LaRosa JC.

    Curr Atheroscler Rep. 2003 Sep;5(5):379-85. Review. No abstract available. PMID: 12911848 [PubMed - indexed for MEDLINE]Related articles

    25.

    Understanding risk in hypercholesterolemia.

    LaRosa JC.

    Clin Cardiol. 2003 Jan;26(1 Suppl 1):I3-6. Review.PMID: 12539815 [PubMed - indexed for MEDLINE]Related articles

    26.

    What do the statins tell us?

    LaRosa JC.

    Am Heart J. 2002 Dec;144(6 Suppl):S21-6. Review.PMID: 12486412 [PubMed - indexed for MEDLINE]Related articles

    27.

    Justifying lipid-lowering therapy in persons >/=65 years of age.

    LaRosa JC.

    Am J Cardiol. 2002 Dec 15;90(12):1330-2. No abstract available. PMID: 12480043 [PubMed - indexed for MEDLINE]Related articles

    28.

    Highlighting the unmet need for prevention: an epidemiologic perspective.

    LaRosa JC.

    Postgrad Med. 2002 Oct;112(4 Suppl):6-11.PMID: 19667594 [PubMed - indexed for MEDLINE]Related articles

    29.

    Outcomes of lipid-lowering treatment in postmenopausal women.

    LaRosa JC.

    Drugs Aging. 2002;19(8):595-604. Review.PMID: 12207553 [PubMed - indexed for MEDLINE]Related articles

    30.

    Use of statin drugs in women.

    LaRosa JC.

    J Hypertens Suppl. 2002 May;20(2):S70-2.PMID: 12183858 [PubMed - indexed for MEDLINE]Related articles

    32.

    Prevention and treatment of coronary heart disease: who benefits?

    LaRosa JC.

    Circulation. 2001 Oct 2;104(14):1688-92.PMID: 11581150 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Pleiotropic effects of statins and their clinical significance.

    LaRosa JC.

    Am J Cardiol. 2001 Aug 1;88(3):291-3. Review. No abstract available. PMID: 11472710 [PubMed - indexed for MEDLINE]Related articles

    34.

    Poor compliance: the hidden risk factor.

    LaRosa JC.

    Curr Atheroscler Rep. 2000 Jan;2(1):1-4. No abstract available. PMID: 11122718 [PubMed - indexed for MEDLINE]Related articles

    35.

    Enhancing drug compliance in lipid-lowering treatment.

    LaRosa JH, LaRosa JC.

    Arch Fam Med. 2000 Nov-Dec;9(10):1169-75. Review.PMID: 11115225 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Statins and risk of coronary heart disease

    LaRosa JC.

    JAMA. 2000 Jun 14;283(22):2935-6. No abstract available. PMID: 10865268 [PubMed - as supplied by publisher]Related articles

    37.

    Atherogenesis and its relationship to coronary risk factors.

    LaRosa JC.

    Clin Cornerstone. 1998 Jun-Jul;1(1):3-14. Review.PMID: 10682160 [PubMed - indexed for MEDLINE]Related articles

    38.

    Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

    LaRosa JC, He J, Vupputuri S.

    JAMA. 1999 Dec 22-29;282(24):2340-6.PMID: 10612322 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Future cardiovascular end point studies: where will the research take us?

    LaRosa JC.

    Am J Cardiol. 1999 Aug 15;84(4):454-8. Review.PMID: 10468086 [PubMed - indexed for MEDLINE]Related articles

    40.

    Tulane investigation completed.

    LaRosa JC.

    Science. 1999 Jun 18;284(5422):1932. No abstract available. PMID: 10400534 [PubMed - indexed for MEDLINE]Related articles

    41.

    Academic medicine and managed care: seeking common ground.

    LaRosa JC, Whelton P, Litwin MS.

    Acad Med. 1999 May;74(5):488-92.PMID: 10353278 [PubMed - indexed for MEDLINE]Related articles

    42.

    The role of diet and exercise in the statin era.

    LaRosa JC.

    Prog Cardiovasc Dis. 1998 Sep-Oct;41(2):137-50. Review.PMID: 9790414 [PubMed - indexed for MEDLINE]Related articles

    43.

    Women, dyslipoproteinemia, and estrogens.

    LaRosa JC.

    Endocrinol Metab Clin North Am. 1998 Sep;27(3):627-39, x. Review.PMID: 9785057 [PubMed - indexed for MEDLINE]Related articles

    44.

    Cholesterol & atherosclerosis: a controversy resolved.

    LaRosa JC.

    Adv Nurse Pract. 1998 May;6(5):36-7, 39-41. Review.PMID: 9633288 [PubMed - indexed for MEDLINE]Related articles

    45.

    What kinds of studies should be required to probe efficacy and safety of drugs in special populations?

    LaRosa JC, Sneider GB, Boyle C.

    Am J Cardiol. 1998 Apr 23;81(8A):84F-87F. Review. No abstract available. PMID: 9604921 [PubMed - indexed for MEDLINE]Related articles

    46.

    Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis.

    Olson BH, Anderson SM, Becker MP, Anderson JW, Hunninghake DB, Jenkins DJ, LaRosa JC, Rippe JM, Roberts DC, Stoy DB, Summerbell CD, Truswell AS, Wolever TM, Morris DH, Fulgoni VL 3rd.

    J Nutr. 1997 Oct;127(10):1973-80.PMID: 9311953 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Triglycerides and coronary risk in women and the elderly.

    LaRosa JC.

    Arch Intern Med. 1997 May 12;157(9):961-8. Review.PMID: 9140266 [PubMed - indexed for MEDLINE]Related articles

    48.

    Cholesterol management in women and the elderly.

    LaRosa JC.

    J Intern Med. 1997 Apr;241(4):307-16. Review.PMID: 9159602 [PubMed - indexed for MEDLINE]Related articles

    49.

    Cholesterol screening guidelines consensus, evidence, and the departure from common sense.

    LaRosa JC, Pearson TA.

    Circulation. 1997 Mar 18;95(6):1651-3. No abstract available. PMID: 9118537 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Estrogen replacement therapy and coagulation: relationship to lipid and lipoprotein changes.

    Kessler CM, Szymanski LM, Shamsipour Z, Muesing RA, Miller VT, LaRosa JC.

    Obstet Gynecol. 1997 Mar;89(3):326-31.PMID: 9052579 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...